Company Name
Savara Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US8051111016
CIK:
0001160308
CUSIP:
00764X103
Currency:
USD
Full Time Employees:
59
Phone:
512 614 1848
Website:
https://www.savarapharma.com
Fiscal Year End:
December
IPO Date:
Jun 01, 2017
Description:
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Address:
1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047